NewsFlash Archive

more Events

Subscribe

  • 0%
    0 votes

    Anthera Initiates Expanded and Extended PEARL-SC Phase 2b Clinical Study in Lupus With A623 - a Subcutaneous Dual Inhibitor of Membrane and Soluble B-Cell Activating Factor (BAFF or BLyS)

    Friday, July 30, 2010

    HAYWARD, Calif. -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for

    read more>>

  • 0%
    0 votes

    Clearing a Large Hurdle

    Thursday, May 20, 2010

    The legs that made Glenn Powell the fastest kid in Belzer Middle School suddenly couldn't carry him across a hospital roomFive years ago, the current Lawrence Central High School hurdler contracted CIDP (chronic inflammatory demyelinating polyneuropathy), a rare neurological disorder that weakens

    read more>>

  • 0%
    0 votes

    Walk in Portland Raises Money, Awareness for Obscure Disease

    Wednesday, April 28, 2010

    PORTLAND -- Spring is in the air, and people have cleaning their sneakers to do some walkingSo, why not take a walk for a causeThe first "Stepping Out to Cure Scleroderma" walk-a-thon is scheduled for May 15. Organizer Lori Chason hopes the walk will raise funds and awareness for a disease she ha

    read more>>

  • 0%
    0 votes

    New High Purity Immunoglobulin Enters Phase III in Europe and the US

    Tuesday, February 16, 2010

    LACHEN, Switzerland -- Octapharma AG today announced the start of the first of a series of Phase III studies for its new 10% high purity intravenous immunoglobulin (IVIGThe study will investigate the efficacy and safety of this novel immunoglobulin in the treatment of primary immune deficiency and

    read more>>

  • 0%
    0 votes

    From Fat to Chronic Inflammation

    Wednesday, September 2, 2009

    Researchers may have found a key ingredient in the recipe that leads from obesity to chronic low-grade inflammation, according to a report in the September issue of Cell Metabolism, a Cell Press publication.

    read more>>

  • 0%
    0 votes

    Amarin Announces Results From Exploratory Phase 2a Study of EN101 in Myasthenia Gravis

    Thursday, June 11, 2009

    DUBLIN -- Amarin Corporation plc (NASDAQ:AMRN) today announced encouraging top line results from an exploratory Phase 2a multi-centre, dose-ranging, cross-over clinical study of EN101 in patients with myasthenia gravis, a chronic autoimmune disease characterized by muscle weakness which can be life-threatening.

    read more>>

  • 0%
    0 votes

    CIDP Treated With Plasma-Derived Therapy

    Monday, April 27, 2009

    Chronic inflammatory demyelinating polyneuropathy (CIDP) is a debilitating, progressive neurological disorder that results in muscle weakness and fatigue and can severely impair motor skills. According to the GBS/CIDP Foundation International, CIDP affects two to seven individuals per 100,000 worldwide. The rare disease is treated with intravenous immune globulin (IVIG), a plasma-derived therapy…

    read more>>

  • 0%
    0 votes

    Rural Akron Man Fights His Way Back to Mobility

    Friday, March 27, 2009

    About two months ago, Plymouth County farmer Jeff Klemme was looking at the possibility of being in a wheelchair his entire life.He couldn't unclench his hand without help, much less get out of a chair.Klemme -- husband, father of three, and involved in everything from farming and delivering propane to serving as a Plymouth County Fair Board member -- was essentially paralyzed.Now he's getting…

    read more>>

  • 0%
    0 votes

    White Plains Woman Battles Rare Disease

    Tuesday, February 24, 2009

    WHITE PLAINS - For the most part, Portia Goss is a typical mom.She reads bedtime stories to her sons. She cooks for them. She plays plenty of games with them. She also helps them with their homework, and they even help her with hers.While Goss’ sons were learning how to write, so was she.Learning how to write again was one of the many obstacles Goss faced when she was struck with Chronic…

    read more>>

  • 0%
    0 votes

    In the Grasps of Pain

    Tuesday, January 13, 2009

    DANVILLE - When Shaun Zimmerman and Breanne Earlston, both of Danville, learned their then 4-month-old daughter Kyla had a rare disease that affected her entire nervous system and was causing her intense pain, they began a frantic quest to find the most knowledgeable doctors and best hospitals that could help her.Their journey took them from Geisinger Medical Center in Danville to Philadelphia's…

    read more>>